Price target
33.070.000.00%
The 5 analysts offering 1 year price forecasts for A3D4A6 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to A3D4A6 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
A3D4A6 EPS for the last quarter is −2.20 EUR despite the estimation of −3.82 EUR. In the next quarter EPS is expected to reach −3.38 EUR. Track more of Cidara Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Cidara Therapeutics, Inc. revenue is expected to reach 231.83 K EUR. Check out Cidara Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, A3D4A6 price target is 33.07 EUR with a max estimate of 43.52 EUR and a min estimate of 23.21 EUR. Check if this forecast comes true in a year, meanwhile watch Cidara Therapeutics, Inc. stock price chart and keep track of the current situation with A3D4A6 news and stock market news.
We've gathered opinions of 6 analysts rating A3D4A6 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.